Immunotherapy Treatments
Why did Pharmac wait on funding Opdivo, Keytruda?
1 Jul 2016
Why did cancer patients in New Zealand have to wait so long for Keytruda? Sarah Fitt, Pharmac's Director of Operations, joins Checkpoint. Audio
Wait for Keytruda, Opdivo too long, say expert
1 Jul 2016
Oncologists throughout the country, as well as the Cancer Society of New Zealand, have been asking for immunotherapy treatments for melanoma from Pharmac since last year. Video, Audio
Advanced melanoma patient receives Keytruda infusion
1 Jul 2016
From today, patients with advanced melanoma will be able to access two publicly funded immunotherapy treatments - Opdivo and Keytruda, including Aucklander Barry Hawes. Video, Audio